Cargando…

Peptide‐2 from mouse myostatin precursor protein alleviates muscle wasting in cancer‐associated cachexia

Cancer cachexia, characterized by continuous muscle wasting, is a key determinant of cancer‐related death; however, there are few medical treatments to combat it. Myostatin (MSTN)/growth differentiation factor 8 (GDF‐8), which is a member of the transforming growth factor‐β family, is secreted in an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ojima, Chiharu, Noguchi, Yuri, Miyamoto, Tatsuki, Saito, Yuki, Orihashi, Hiroki, Yoshimatsu, Yasuhiro, Watabe, Tetsuro, Takayama, Kentaro, Hayashi, Yoshio, Itoh, Fumiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419029/ https://www.ncbi.nlm.nih.gov/pubmed/32519375 http://dx.doi.org/10.1111/cas.14520

Ejemplares similares

Combination therapy with anamorelin and a myostatin inhibitor is advantageous for cancer cachexia in a mouse model
por: Hanada, Kako, et al.
Publicado: (2022)

The Inhibitory Core of the Myostatin Prodomain: Its Interaction with Both Type I and II Membrane Receptors, and Potential to Treat Muscle Atrophy
por: Ohsawa, Yutaka, et al.
Publicado: (2015)

Increasing Skeletal Muscle Mass in Mice by Non-Invasive Intramuscular Delivery of Myostatin Inhibitory Peptide by Iontophoresis
por: Michiue, Kohki, et al.
Publicado: (2023)

Myostatin is a novel tumoral factor that induces cancer cachexia
por: Lokireddy, Sudarsanareddy, et al.
Publicado: (2012)

Myostatin is a novel tumoral factor that induces cancer cachexia
por: Lokireddy, Sudarsanareddy, et al.
Publicado: (2016)

Myostatin Levels and the Risk of Myopenia and Rheumatoid Cachexia in Women with Rheumatoid Arthritis
por: Gonzalez-Ponce, Fabiola, et al.
Publicado: (2022)

TGF-β signaling in lymphatic vascular vessel formation and maintenance
por: Itoh, Fumiko, et al.
Publicado: (2022)

Roles of TGF-β Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2011)

Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and disease
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2022)

The role of myostatin in muscle wasting: an overview
por: Elkina, Yulia, et al.
Publicado: (2011)

Cytotoxic Aggregation and Amyloid Formation by the Myostatin Precursor Protein
por: Starck, Carlene S., et al.
Publicado: (2010)

Transforming growth factor‐β signaling enhancement by long‐term exposure to hypoxia in a tumor microenvironment composed of Lewis lung carcinoma cells
por: Furuta, Chiaki, et al.
Publicado: (2015)

Cardiac muscle wasting in individuals with cancer cachexia
por: Barkhudaryan, Anush, et al.
Publicado: (2017)

Cardiac Cachexia - A Window to the Wasting Disorders
por: Coats, Andrew J Stewart
Publicado: (2018)

Mathematical Model of Muscle Wasting in Cancer Cachexia
por: Farhang-Sardroodi, Suzan, et al.
Publicado: (2020)

Inflammation and Skeletal Muscle Wasting During Cachexia
por: Webster, Justine M., et al.
Publicado: (2020)

Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021)

Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders
por: Smith, Rosamund C., et al.
Publicado: (2013)

Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
por: Pirruccello-Straub, M., et al.
Publicado: (2018)

Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020)

Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1
por: Tao, Weili, et al.
Publicado: (2023)

Exploring the Therapeutic Potential of Ethyl 3-Hydroxybutyrate in Alleviating Skeletal Muscle Wasting in Cancer Cachexia
por: Zhou, Yu, et al.
Publicado: (2023)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2019)

Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2020)

Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps
por: Baczek, Jan, et al.
Publicado: (2020)

Cachexia and protein-energy wasting in children with chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia
por: Müller, Timo D., et al.
Publicado: (2010)

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia
por: Aquila, Giorgio, et al.
Publicado: (2020)

Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
por: Yeom, Eunbyul, et al.
Publicado: (2022)

Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis
por: Miyazaki, Hideki, et al.
Publicado: (2014)

Dual targeting of vascular endothelial growth factor and bone morphogenetic protein‐9/10 impairs tumor growth through inhibition of angiogenesis
por: Akatsu, Yuichi, et al.
Publicado: (2017)

Construction of transplantable artificial vascular tissue based on adipose tissue-derived mesenchymal stromal cells by a cell coating and cryopreservation technique
por: Asano, Yoshiya, et al.
Publicado: (2021)

Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
por: Baig, Mohammad Hassan, et al.
Publicado: (2022)

TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2020)

The role of insulin resistance in the development of muscle wasting during cancer cachexia
por: Honors, Mary A., et al.
Publicado: (2011)

Why cachexia kills: examining the causality of poor outcomes in wasting conditions
por: Kalantar-Zadeh, Kamyar, et al.
Publicado: (2013)

Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2016)

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia
por: Ábrigo, Johanna, et al.
Publicado: (2018)

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
por: Chiappalupi, Sara, et al.
Publicado: (2020)

Fat Wasting Is Damaging: Role of Adipose Tissue in Cancer-Associated Cachexia
por: Sun, Xiaoting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s9bbsdbk8okqadlq2uovht95lu